With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
WELL trades against a final fair-value range of $56.34-$78.60, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A sustained high-interest-rate environment coupled with sticky healthcare labor inflation would severely constrain accretive acquisitions while crushing property-level operating margins, driving valuation sharply toward the $56.34 low.
Prolonged high interest rates severely limit accretive acquisition volume and compress real estate cap rates across the sector.
Persistent shortages in healthcare staffing drive runaway wage inflation, permanently squeezing operator margins and reducing AFFO generation.
Competitors massively overbuild in key micro-markets ahead of the aging wave, crushing occupancy and pricing power.
| Line item | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|
| Revenue | $5.78B | $6.48B+12.1% | $7.85B+21.1% | $10.67B+35.9% | +22.7% |
| Gross profit | $2.22B | $2.53B | $3.02B | $4.18B | +23.5% |
| Operating income | $746.2M | $940.5M | $1.15B | $355.2M | -21.9% |
| Net income | $141.2M | $340.1M+140.9% | $951.7M+179.8% | $936.8M-1.6% | +87.9% |
| EPS (diluted) | $0.30 | $0.66 | $1.57 | $1.39 | +66.7% |
| EBITDA | $2.04B | $2.40B | $2.78B | $2.31B | +4.2% |
| R&D | — | — | — | — | — |
| SG&A | $150.4M | $179.1M | $235.5M | $1.75B | +126.5% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Surging operator labor costs per occupied unit compressing site-level EBITDAR. | Monitor | Deterioration versus the report thesis |
| Multiple expansion on recently closed asset sales indicating market exhaustion. | Monitor | Deterioration versus the report thesis |
